40 Participants NeededMy employer runs this trial

RENEW for Ankylosing Spondylitis

EH
Overseen ByElizabeth Haro
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Michigan
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a web-based program called RENEW, designed to help people with axial spondyloarthritis (axSpA) manage their symptoms and energy levels. The study aims to assess the program's usability, participant satisfaction, and effectiveness in alleviating symptoms. Participants will either begin using the program with guidance from a peer health coach or join a waitlist to try it later. It suits those diagnosed with axSpA who often experience fatigue and are open to exploring new online health tools. As an unphased trial, this study provides a unique opportunity to investigate innovative online tools for managing axSpA symptoms.

What prior data suggests that the RENEW program is safe for people with axial spondyloarthritis?

The RENEW program is an online tool designed to help people manage symptoms of axial spondyloarthritis (axSpA). As it is neither a medication nor a medical device, it lacks traditional safety concerns such as side effects. While direct research evidence about its safety is unavailable, the program involves minimal risk because peers—individuals with experience in spondyloarthritis—lead it. Participants engage with these peer health coaches in a supportive and user-friendly manner, making it comfortable for most people.12345

Why are researchers excited about this trial?

Unlike traditional treatments for ankylosing spondylitis, which typically include medications like NSAIDs, TNF inhibitors, and IL-17 inhibitors, the RENEW program focuses on a holistic, peer-supported approach. This treatment stands out because participants are guided by peer health coaches who have personal experience with spondyloarthritis, providing a unique, empathetic support system. Researchers are excited about this trial because it explores the potential benefits of peer coaching, which could lead to improved patient outcomes by offering tailored emotional and practical support that current medical treatments do not address.

What evidence suggests that the RENEW program is effective for managing symptoms of ankylosing spondylitis?

Research shows that exercise programs can significantly help manage symptoms in people with ankylosing spondylitis, a type of arthritis that affects the spine. Studies have found that supervised exercise can improve disease control and enhance the quality of life for these patients. In this trial, participants in Group 1 will engage in the RENEW program, which emphasizes peer support and guidance to encourage regular physical activity. This approach aims to help people with axial spondyloarthritis manage their symptoms better. Although specific data on RENEW's effectiveness is not yet available, its approach is based on proven methods for reducing the disease's impact.678910

Who Is on the Research Team?

SM

Susan Murphy, ScD, OTR

Principal Investigator

University of Michigan

YC

Yen Chen, PhD

Principal Investigator

University of Michigan

Are You a Good Fit for This Trial?

This trial is for adults diagnosed with axial spondyloarthritis or ankylosing spondylitis who want help managing their symptoms and energy levels. Participants should be able to use a web-based program.

Inclusion Criteria

I am open to making changes to improve my health and well-being.
I have been diagnosed with axial spondyloarthritis by my doctor.
I am willing to join Zoom coaching sessions and complete online assessments.
See 3 more

Exclusion Criteria

I do not have significant cognitive problems that prevent me from understanding or participating.
I am currently receiving treatment for major depression.
Currently enrolled in other clinical trials
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in the RENEW program with peer health coaching for symptom management

12 weeks
Web-based sessions

Follow-up

Participants are monitored for feedback and effectiveness of the RENEW program

4 weeks

Optional Interview

Participants may be invited to a 30-minute interview to share feedback about their experience with RENEW

What Are the Treatments Tested in This Trial?

Interventions

  • RENEW

Trial Overview

The study is testing RENEW, an online peer-led program designed to help people with axial spondyloarthritis manage their symptoms and daily energy. The focus is on how easy it is to use, if participants like it, and whether it helps reduce disease impact.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Group 1: RENEW ProgramExperimental Treatment1 Intervention
Group II: Group 2: Waitlist GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials
1,891
Recruited
6,458,000+

Spondyloarthritis Association of America

Collaborator

Citations

Long-term efficacy and safety of secukinumab 150 mg ... - PMC

This study aimed to report end-of-study results on efficacy and safety of secukinumab 150 mg through 5 years in patients with ankylosing ...

Supervised Exercise Most Effective for Managing Axial ...

NIH – Underweight and obesity are strong predictors of clinical outcomes in patients with ankylosing spondylitis: data from the Smart-phone ...

Effectiveness of Exercise Programs in Ankylosing Spondylitis

To assess the effectiveness of exercise programs on disease activity and function in ankylosing spondylitis (AS) by a systematic review and meta ...

Update on New Research in Spondyloarthritis - Dxlink

Secukinumab demonstrates low radiographic progression and sustained efficacy through 4 Years in patients with active ankylosing spondylitis.

2019 Update of the American College of Rheumatology ...

To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and outcomes; and outcomes;

6.

renew.com

renew.com/

Global Leading Renewable & Green Energy Company | ReNew

ReNew is committed to becoming a net-zero company by 2040. ReNew's renewable energy projects serve to reduce around 0.5% of India's carbon emissions, ...

reNEW: Innovative stem cell research to treat and cure diseases

reNEW is transforming lives with cutting edge stem cell research. We use this knowledge to develop novel drugs and therapies to treat and cure diseases.

Renew | Grant County, WA

Renew offers services for children, teens, adults, and families throughout Grant County. Explore the services below to find the support that fits your needs.

Renew Europe: The Europe We Build Together

We turn ideas into action. Championing prosperity, sustainability, and democracy for a Europe that moves forward together.

Maximize Revenue with Our Retention Management Platform

Discover how Renew's platform empowers you to manage renewals, enhance revenue, and retain residents effortlessly across your portfolio.